# FDA Inspection 1301040 - Regeneron Pharmaceuticals, Inc. - March 27, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/regeneron-pharmaceuticals-inc/296ba636-d4d0-4d53-8759-4f578b9375a0
Source feed: FDA_Inspections

> FDA Inspection 1301040 for Regeneron Pharmaceuticals, Inc. on March 27, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301040
- Company Name: Regeneron Pharmaceuticals, Inc.
- Inspection Date: 2026-03-27
- Product Type: Human Drugs
- Office Name: New York District Office

Company: https://www.globalkeysolutions.net/companies/regeneron-pharmaceuticals-inc/66cc832e-01c6-4a53-8506-f897dcf4c0d3

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d